26 unchanged sentences
Significant changes from the prior year include:
−Removed: Professional fees decreased by $10,350, year over year going to $144,807 from $155,157 as legal fees decreased and overcame an increase in auditing fees.
−Removed: Accounting activity remained unchanged over prior year totals.
−Removed: Share-based compensation increased to $5,416 from $Nil.
−Removed: The company issued share options as a form of compensation to a consultant.
−Removed: Research and development decreased by $12,819 from $112,444 to $99,625 as the Company scaled back on new research and moves toward leveraging the positive study findings.
+Added: Professional fees increased by $32,804, year over year going to $177,610 from $144,806 as fees increased largely due to legal work for shareholder voting regarding increasing authorized shares of common stock, and legal work regarding valuation report of patent portfolio.
+Added: Share-based compensation decreased from $5,417 to $nil.
+Added: The company did not issue share options as a form of compensation during the year ended 2025.
+Added: Research and development increased by $6,988 from $99,625 to $106,613 due to an increase in storage fees for the molecule inventory.
+Added: The Company has scaled back on new research and moves toward leveraging the positive study findings.
New projects will be targeted investments expanding the development of the AAGP ® molecule through institutional collaborations and industry partnerships.
12 unchanged sentences
Working Capital
−Removed: At December 31, 2024, we had a $4,697 shortfall in
−Removed: cash and negative $3,647 in total current assets.
−Removed: As of December 31, 2024, we had a negative working capital equity deficit position
−Removed: Although as of the date of this Annual Report we do not believe we have sufficient capital to meet cash flow projections
−Removed: and carry forward our business objectives in the short-term, the Company will need additional working capital to continue its medical
−Removed: research or to be successful in any future business activities and continue to pay its liabilities.
−Removed: There can be no assurance that
−Removed: in the future we will be able to raise capital from outside sources in sufficient amounts to fund our business.
+Added: At December 31, 2025, we had $1,118 in cash and $2,168
+Added: in total current assets.
+Added: As of December 31, 2025, we had a negative working capital equity deficit position of $183,266.
+Added: as of the date of this Annual Report we do not believe we have sufficient capital to meet cash flow projections and carry forward our
+Added: business objectives in the short-term, the Company will need additional working capital to continue its medical research or to be successful
+Added: in any future business activities and continue to pay its liabilities.
+Added: There can be no assurance that in the future we will be able
+Added: to raise capital from outside sources in sufficient amounts to fund our business.
The failure to secure adequate outside funding would
4 unchanged sentences
During the year ended December 31, 2025, net cash
−Removed: used in operating activities decreased $152,939 from $375,989 to $223,050 for the years ended December 31, 2023 and 2024, respectively.
−Removed: This decrease was predominantly due to the overall decreased spending on web marketing, news releases, and social media, as well as significant
−Removed: reduction in new research spending.
−Removed: Informative updates have been posted on the Company website, reducing the need for news releases and
−Removed: associated expenses.
+Added: provided by operating activities decreased by $87,673 from a use of $223,050 to $135,377 provided for the years ended December 31, 2024
+Added: and 2025, respectively.
+Added: This change was predominantly due to increase in accounts payable.
Net Cash Used in Investing Activities
During the year ended December 31, 2025, net cash
−Removed: used in investing activities decreased slightly by $1,098 as we continue to maintain global patent applications.
−Removed: Current year spending
−Removed: was narrowed to maintenance of existing patent family.
+Added: used in investing activities decreased by $1,747 as we continue to maintain global patent applications.
+Added: Current year spending was narrowed
+Added: to maintenance of existing patent family.
Net cash used for investing activities for the year ended December 31, 2024 was $58,055.
2 unchanged sentences
During the year ended December 31, 2025, net cash
−Removed: provided by financing activities reduced by $174,000 from $430,000 to $256,000 for the years ended December 31, 2023 and 2024 respectively.
+Added: provided by financing activities decreased by $58,500 from $256,000 to $197,500 for the years ended December 31, 2024 and 2025 respectively.
This decrease was predominantly due to a reduction in funding of new research through private placement of common stock shares.
86 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.